3 San Antonio Studies Target Androgen in Breast Cancer
December 11, 2014 · Comments Off on 3 San Antonio Studies Target Androgen in Breast Cancer
Three studies presented by University of Colorado Cancer Center researchers at the San Antonio Breast Cancer Symposium 2014 demonstrate the effects of blocking androgen receptors in breast cancer.
Study Shows Anti-Androgen Receptor Therapy for Triple-Negative Breast Cancer May Benefit More Than Just High-Androgen Receptor Tumors
June 23, 2014 · Comments Off on Study Shows Anti-Androgen Receptor Therapy for Triple-Negative Breast Cancer May Benefit More Than Just High-Androgen Receptor Tumors
A new University of Colorado Cancer Center study being presented today at the Endocrine Society Annual Meeting shows that even triple negative breast cancers expressing very low levels of androgen receptor may benefit from anti-androgen therapies.
May 31, 2013 · Comments Off on Stop Signals
Researchers at University of Colorado Cancer Center are discovering how androgens drive diseases such as breast and bladder cancers.
AACR News: Studies show increasing evidence that androgen drives breast cancer
April 10, 2013 · Comments Off on AACR News: Studies show increasing evidence that androgen drives breast cancer
Estrogen and progesterone receptors, and the gene HER2 – these are the big three markers and/or targets in breast cancer. Evidence presented at the AACR Annual Meeting 2013 adds a fourth: androgen receptors.
Longer life expectancy, aging population necessitate new strategies for prostate cancer care
December 4, 2012 · Comments Off on Longer life expectancy, aging population necessitate new strategies for prostate cancer care
Members of the University of Colorado Cancer Center recently published a review in the journal Drugs and Aging describing the modern state of prostate cancer care – examining not only new drugs but entirely new classes of drugs that may be effective and well-tolerated in our aging population.
Clinical trial hits new target in war on breast cancer
December 3, 2012 · Comments Off on Clinical trial hits new target in war on breast cancer
KEY POINTS: In addition to estrogen, progesterone and HER2, androgen drives breast cancer The drug...
Outliving the Odds
November 30, 2012 · Comments Off on Outliving the Odds
In 20 years, Harry Peterson exhausts his doctor's 'Bag of Tricks," finds hope in a clinical trial.
Enzalutamide adds five months survival in late-stage prostate cancer
August 16, 2012 · Comments Off on Enzalutamide adds five months survival in late-stage prostate cancer
Results of a phase III clinical trial of the drug Enzalutamide, published yesterday in the...
Dietary supplements shown to increase cancer risk
August 16, 2012
AACR amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer prevention cancer research colorado Cancer Survivorship clinical trial colon cancer colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Have a wonderful weekend! http://t.co/GkkGFDflE9
CU researcher used human blood stem cells to grow “humanized” mouse immune system prior to tumor transplantation ow.ly/M22Pq
Today is the start to @CancerCon! We hope to see you at our booth!